Pfizer, NCCN give $2M in cancer research grants to six winners

June 06, 2014

By Jennifer Bresnick
June 06, 2014 - Pfizer and the National Comprehensive Cancer Network (NCCN) Oncology Research Program have awarded grants to six research and academic institutions focused on consumer education, medical research, and care coordination for cancer patients.  Projects focused on renal cell carcinoma and hematologic malignancies will share more than $2 million between them.
“The NCCN ORP is extremely pleased that this collaborative initiative with Pfizer has funded important research-based education that has the potential to significantly improve the quality of care for patients with renal or hematologic malignancies,” said Diane E. Paul, MS, RN, Vice President, NCCN ORP.
The grantees are as follows:
Fred and Pamela Buffett Cancer Center at the University of Nebraska Medical Center: Project EXTEND: A Community Extended Case Conference to Improve Lymphoma Care
Dig Deeper
$240M IBM, MIT Artificial Intelligence Lab Has Healthcare Focus
Clinical Analytics Studies, Partnerships Target Personalized Care
NIH to Bring Precision Medicine Data Collection to Patient Homes
Duke Cancer Institute: Novel Educational Interventions for Community Oncologists and Patients to Optimize Renal Cell Carcinoma Outcomes
East Carolina University: Enhancing Provider Education and Improving Healthcare Disparities in Chronic Myeloid Leukemia (CML) and Multiple Myeloma (MM) through a Rural Regional North Carolina Hospital Network
Fox Chase Cancer Center: Improving the Care of Patients with Metastatic Renal Cell Carcinoma (mRCC) via a Patient and Provider Intervention Program
National Marrow Donor Program: Referral for Hematopoietic Cell Transplantation for Hematologic Malignancies: Addressing Clinical Practice and Education Gaps among Oncologists
University of Colorado Cancer Center: Determining and Addressing Adherence to the NCCN Guidelines for Chronic Phase CML
Tagged Applied AnalyticsClinical AnalyticsMedical Research


